159 related articles for article (PubMed ID: 2852221)
1. Podophyllotoxins for brain metastases of small cell lung cancer.
Haaxma-Reiche H; Berendsen HH; Postmus PE
J Neurooncol; 1988 Nov; 6(3):231-2. PubMed ID: 2852221
[TBL] [Abstract][Full Text] [Related]
2. Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
Giaccone G; Donadio M; Bonardi GM; Testore F; Calciati A
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):629-31. PubMed ID: 2838291
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Radice PA; Bunn PA; Ihde DC
Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
[No Abstract] [Full Text] [Related]
4. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group.
Postmus PE; Haaxma-Reiche H; Smit EF; Groen HJ; Karnicka H; Lewinski T; van Meerbeeck J; Clerico M; Gregor A; Curran D; Sahmoud T; Kirkpatrick A; Giaccone G
J Clin Oncol; 2000 Oct; 18(19):3400-8. PubMed ID: 11013281
[TBL] [Abstract][Full Text] [Related]
5. Remission of brain metastases from small-cell lung cancer after high-dose chemotherapy.
Postmus PE; Haaxma-Reiche H; Vencken LM; Meinesz AF; Sleijfer DT; Mulder NH
Ann Intern Med; 1984 Nov; 101(5):717. PubMed ID: 6091514
[No Abstract] [Full Text] [Related]
6. Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration.
Postmus PE; Holthuis JJ; Haaxma-Reiche H; Mulder NH; Vencken LM; van Oort WJ; Sleijfer DT; Sluiter HJ
J Clin Oncol; 1984 Mar; 2(3):215-20. PubMed ID: 6321690
[TBL] [Abstract][Full Text] [Related]
7. Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.
Bork E; Ersbøll J; Dombernowsky P; Bergman B; Hansen M; Hansen HH
J Clin Oncol; 1991 Sep; 9(9):1627-31. PubMed ID: 1651994
[TBL] [Abstract][Full Text] [Related]
8. Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Postmus PE; Smit EF; Haaxma-Reiche H; van Zandwijk N; Ardizzoni A; Quoix E; Kirkpatrick A; Sahmoud T; Giaccone G
J Clin Oncol; 1995 Mar; 13(3):660-5. PubMed ID: 7884426
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies in relation to drug action.
Muggia FM; McVie G
NCI Monogr; 1987; (4):129-33. PubMed ID: 2819724
[No Abstract] [Full Text] [Related]
10. Treatment of brain metastases of small cell lung cancer with teniposide.
Postmus PE; Smit EF; Berendsen HH; Sleijfer DT; Haaxma-Reiche H
Semin Oncol; 1992 Apr; 19(2 Suppl 6):89-94. PubMed ID: 1329230
[TBL] [Abstract][Full Text] [Related]
11. [Controversial treatment of brain metastases of small-cell lung cancer. Randomized comparison of chemotherapy alone and radiochemotherapy].
Fietkau R
Strahlenther Onkol; 2001 Jun; 177(6):314-6. PubMed ID: 11446322
[No Abstract] [Full Text] [Related]
12. Phase II study of teniposide in small cell carcinoma of the lung.
Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
[TBL] [Abstract][Full Text] [Related]
13. Resolution of small cell lung cancer intracranial metastases with standard dose chemotherapy.
Kearns F; Grogan L; Harford P; Carney DN
Ir J Med Sci; 1989 Dec; 158(12):308-9. PubMed ID: 2560771
[TBL] [Abstract][Full Text] [Related]
14. In vitro antitumor activity of teniposide against carcinoma of the lung in human tumor clonogenic assay.
Matsushima Y; Kanzawa F; Miyazawa N; Sasaki Y; Saijo N
Anticancer Res; 1986; 6(5):921-4. PubMed ID: 3026235
[TBL] [Abstract][Full Text] [Related]
15. High-dose etoposide for central nervous system metastases of small cell lung cancer. Preliminary results.
Postmus PE; Haaxma-Reiche H; Sleijfer DT; Kleisbauer JP; ten Velde G; Kirkpatrick A
Eur J Respir Dis Suppl; 1987; 149():65-71. PubMed ID: 3034652
[TBL] [Abstract][Full Text] [Related]
16. Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC).
Cerny T; Pedrazzini A; Joss RA; Brunner KW
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1791-4. PubMed ID: 2850194
[TBL] [Abstract][Full Text] [Related]
17. Comparison between VP 16 and VM 26 in Lewis lung carcinoma of the mouse.
Colombo T; Broggini M; Vaghi M; Amato G; Erba E; D'Incalci M
Eur J Cancer Clin Oncol; 1986 Feb; 22(2):173-9. PubMed ID: 3699080
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
[No Abstract] [Full Text] [Related]
20. Treatment of small cell bronchogenic carcinoma with VM-26.
Woods RL; Fox RM; Tattersall MH
Cancer Treat Rep; 1979; 63(11-12):2011-3. PubMed ID: 230897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
